Cargando…
Does Lipocalin-2 Affect Metabolic Syndrome in Hepatic Infections?
Background and objective Lipocalin-2 (LCN-2) is an adipokine that plays a protective role in various inflammatory disorders and regulates innate immune response to acute and chronic infections. However, scant information is available regarding the relationship between serum LCN-2 levels and type 2 d...
Autores principales: | Shahnawaz, Waqas, Suhail, Nawal, Siddiqui, Muhammad Ahsan Iqbal, Yasmeen, Saira, Fatima, Syeda Sadia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515810/ https://www.ncbi.nlm.nih.gov/pubmed/32983730 http://dx.doi.org/10.7759/cureus.10040 |
Ejemplares similares
-
Normal Saline Versus Low Chloride Solutions in Treatment of Diabetic Ketoacidosis: A Systematic Review of Clinical Trials
por: Jahangir, Ahmad, et al.
Publicado: (2022) -
Empagliflozin Ameliorates Progression From Prediabetes to Diabetes and Improves Hepatic Lipid Metabolism: A Systematic Review
por: Hossain, Md Fahad, et al.
Publicado: (2022) -
Follicular Thyroid Carcinoma in a Developing Country: A 10-Year Retrospective Study
por: Aziz, Abdul, et al.
Publicado: (2021) -
The Synergistic Relationship Between Atrial Fibrillation and Diabetes Mellitus: Implications for Cardiovascular and Metabolic Health
por: Mohsin, Maryam, et al.
Publicado: (2023) -
Metabolic Syndrome in Type 2 Diabetes Mellitus Patients: Prevalence, Risk Factors, and Associated Microvascular Complications
por: Asghar, Shoaib, et al.
Publicado: (2023)